NCT07537660 2026-04-17
ADGP
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Recruiting
Clinical Trials
12 trialsNCT07537673 2026-04-17
ADTD
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Recruiting
NCT07537699 2026-04-17
ADDC
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Recruiting
NCT00489307 2025-11-12
Dexamethasone for Symptom Burden in Advanced Cancer Patients
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT00381862 2017-06-12
Phase II Trial of Aprepitant & Palonosetron for CINV Prevention w FOLFOX
OHSU Knight Cancer Institute
Phase 2 Completed
NCT00895245 2017-05-18
Fosaprepitant Dimeglumine, Palonosetron Hydrochloride, and Dexamethasone in Preventing Nausea and Vomiting Caused by Cisplatin in Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy
University of Washington
Phase 2 Terminated
NCT00600353 2017-03-09
Multi-day Doses in Prevention of Nausea and Emesis
University of Kansas Medical Center
Phase 2 Completed
NCT02445872 2015-12-09
Safety and Efficacy of Aprepitant for CINV in Patients With Lung Cancer Receiving Multiple-day Cisplatin Chemotherapy
Zhejiang University
Phase 2 Unknown
NCT02290470 2014-11-14
Olanzapine Against Delayed Nausea and Vomiting in Women Receiving Carboplatin Plus Paclitaxel
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Unknown
NCT00429702 2014-07-25
Diphenhydramine, Lorazepam, and Dexamethasone in Treating Nausea and Vomiting Caused By Chemotherapy
University of South Florida
Phase 2 Terminated
NCT01046461 2012-02-17
RAD
Hallym University Medical Center
Phase 2 Unknown
NCT00169572 2010-05-10
Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based Chemotherapy
GlaxoSmithKline
Phase 2 Completed